This inventor holds 3 USPTO granted patents. Top assignees: Sanofi, Other. Active years: 1995-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1995-1997
Title: The Innovations of Jean-Claude Guillemot
Introduction
Jean-Claude Guillemot is a notable inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the development of proteins with therapeutic applications. With a total of 3 patents to his name, Guillemot's work has the potential to impact various medical treatments.
Latest Patents
Guillemot's latest patents include a protein having interleukin 13 activity, which is crucial for cytokine-type activity. This invention involves a specific amino acid sequence that plays a vital role in its function. Another significant patent is for a new urate oxidase activity protein, which has a defined sequence and is aimed at developing medicines that utilize this protein. The genetic engineering techniques to obtain this protein are also part of his innovative contributions.
Career Highlights
Throughout his career, Guillemot has worked with prominent companies, including Sanofi. His experience in the biotechnology sector has allowed him to develop groundbreaking inventions that address critical health issues.
Collaborations
Guillemot has collaborated with notable professionals in his field, including Daniel Caput and Pascual Ferrara. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
Jean-Claude Guillemot's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile